In contrast, tumor-bearing mice treated with off-target GD2-CAR T cells, off-target CD19-CAR T cells, or mock T cells, exhibit intact behavioral performance in novel object recognition testing (Figure 1G–1I). The gene discussed is CD19; the disease is neoplasm.